Q2 Results Today: 98 Firms Set to Report on October 26

A busy day for September-quarter earnings

As many as 98 companies are scheduled to report their financial results for the July-September quarter on October 26. The list includes One 97 Communications, the parent of Paytm, Tata Consumer Products, REC, Mankind Pharma, Indian Overseas Bank and Bank of Maharashtra. Other companies due to announce earnings include ITC Hotels, APL Apollo Tubes, Dalmia Bharat, Aegis Logistics, Sunteck Realty, Ather Energy, Eris Lifesciences and Nazara Technologies. The concentration of results makes October 26 an important date in the Q2 FY27 earnings calendar. Investors will assess reported revenue, margins, profit or loss, and management commentary after the announcements.

Paytm parent One 97 Communications is in focus

One 97 Communications is among the closely watched companies set to report. The company operates Paytm, a major Indian fintech platform, and its quarterly performance will be assessed against its recent reported financial trend. The supplied Q1 FY27 data shows revenue of ₹83 crore, down 47.32% sequentially and 8.26% year-on-year. It reported a gross loss of ₹11 crore and a net loss of ₹18 crore for that quarter. These figures provide context, but do not indicate the Q2 outcome before the company releases its results.

Financial and banking companies on the calendar

REC, Indian Overseas Bank and Bank of Maharashtra are among the financial-sector names scheduled to announce results. Their disclosures will be relevant for investors tracking lending activity, asset quality, interest income and profitability. REC's quarterly numbers will also be read for trends in its financing operations. For the two banks, the earnings releases will provide their reported financial position for the September quarter. No Q2 financial figures for these companies are available in the provided information ahead of the scheduled announcements.

Consumer, healthcare and industrial companies report

Tata Consumer Products is the leading consumer-sector name in the October 26 results list. Mankind Pharma and Eris Lifesciences represent healthcare, while Dalmia Bharat, APL Apollo Tubes and Aegis Logistics add industrial and infrastructure-linked coverage. ITC Hotels, Sunteck Realty, Ather Energy and Nazara Technologies broaden the set across hospitality, real estate, electric mobility and gaming. The diversity of companies means that the day's announcements will cover several parts of the listed Indian corporate sector. Each company will report its own financial performance and associated disclosures separately.

Astec Lifesciences board meeting is scheduled

Astec Lifesciences has informed the stock exchanges of a board meeting scheduled for Monday, October 26, 2026. The board is due to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026. The results are to be placed before the board after review by the company's Audit Committee. This disclosure is a meeting intimation and does not contain the Q2 financial results or guidance. The formal result filing will determine the company's reported September-quarter performance.

Astec's latest reported financial context

Astec Lifesciences reported revenue from operations of ₹83.6 crore in Q1 FY27, down 8.2% year-on-year, and a net loss of ₹18.7 crore. Its total income for the quarter was ₹84.3 crore, while EBITDA was ₹0.1 crore. For Q2 FY26, the company reported revenue of ₹74 crore and a net loss of ₹24 crore. These figures form the reported year-ago comparison base for the September 2026 quarter. No verified analyst estimate for Astec Lifesciences' Q2 FY27 revenue or profit is included in the supplied material.

Longer-term performance at Astec Lifesciences

For FY26, Astec Lifesciences reported consolidated total income of ₹453.22 crore, compared with ₹386.93 crore in FY25. Its consolidated loss after tax narrowed to ₹80.88 crore from ₹134.71 crore in the prior year. The company manufactures agrochemical active ingredients, bulk products, formulations and intermediates. It sells in India and exports to 19 countries, according to its annual-report disclosure. The annual figures provide background but should not be treated as an indication of the pending Q2 FY27 result.

Key reported figures to track

What investors can verify after the releases

The earnings announcements will provide the first confirmed September-quarter financial figures for the companies named in the schedule. Investors can compare revenue and profitability with the corresponding quarter of the previous year and, where relevant, the preceding quarter. Management statements, board-approved financial results and exchange filings will be the primary sources for assessing company-specific developments. For Astec Lifesciences, the October 26 board meeting is the disclosed event that will consider the quarter and half-year accounts. Until results are filed, no Q2 financial outcome should be assumed.

The significance of October 26 results

The October 26 calendar brings together companies from fintech, banking, consumer products, pharmaceuticals, cement, logistics, real estate, mobility and entertainment. That makes the day relevant for investors following earnings across multiple sectors rather than a single industry. The scheduled releases will add company-level data to the Q2 FY27 reporting season. The immediate focus will remain on the financial figures and disclosures issued by each company. Further details will emerge through the respective exchange announcements following the board meetings and results releases.